-
The use of angiotensin converting enzyme (ACE) inhibitors in all acute myocardial infarction (MI) patients is controversial.
-
Little is known about the long-term prognosis of the no-reflow phenomenon after percutaneous intervention (PCI) for acute ST elevation myocardial infarction (STEMI).
-
Dronedarone is an antiarrhythmic drug with structural and electrophysiologic similarities to amiodarone that was released in 2009. Dronedarone's structure includes a benzofuranyl ring but, unlike amiodarone, the ring is not iodinated.
-
The value of restoring and maintaining sinus rhythm in patients with atrial fibrillation remains controversial.
-
The ACC/AHA guidelines give a class ii b recommendation for surgery in asymptomatic patients if aortic stenosis is very severe (area < 0.6 cm2) and operation risk is low. However, the outcome of this approach vs. following patients until symptoms or left ventricular dysfunction occurs has not been tested.
-
Atrial septal defects (ASD) are among the most common congenital heart defect found in the adult population. Although they are often diagnosed and treated in childhood or infancy, some patients survive into adulthood with unrepaired ASDs.
-
Sudden cardiac death is a feared complication of hypertrophic cardiomyopathy (HCM). Therapies to reduce the incidence of sudden cardiac death have included implantable defibrillators and surgical- and catheter-based approaches to reduce obstruction by septal reduction.
-
-
Fractures and bisphosphonate therapy, warfarin anticoagulation and influenza vaccine and cotrimoxazole, antiplatelet therapy with clopidogrel and aspirin, FDA Actions.
-
Heart failure due to diastolic dysfunction is common in hypertensive patients, yet little is known about the effect of antihypertensive agents on diastolic dysfunction.
